ALXO vs MOS · $207.2M cap vs P/E 161, rev $12.05B
Alx Oncology Holdings (ALXO) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
ALXO does not have a complete income-statement cache yet.
Latest reported MOS revenue for 2025-12-31 was $12.05B. Net income was $540.7M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
ALXO currently screens at market cap $207.2M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the ALXO and MOS stock pages for the full models.
Not investment advice.